News & Updates

April 3, 2025 – The undersigned cancer organizations, which represent people with cancer; cancer health care professionals; researchers; and caregivers, families and friends of those with cancer, issued the following statement in response to the mass reductions in force at the Department of Health and Human Services (HHS) and the reorganization of the department.

In recent years, patients with chronic conditions, including cancer, have faced harmful "copay diversion programs" such as copay accumulators and maximizers. These programs prevent copay assistance payments from counting toward a patient's annual deductible and out-of-pocket maximums. Once the assistance runs out, patients are left with hundreds or thousands of out-of-pocket costs, even though they should have already reached their yearly maximum.

Washington, DC, February 25, 2025 – The House of Representatives will this week consider a budget resolution that instructs the House Energy and Commerce Committee to reduce spending by $880 billion. Most of those cuts are expected to come from Medicaid.

In light of the recent Executive Order regarding federally backed Diversity, Equity, and Inclusion initiatives, certain materials related to clinical trial diversity have been removed from the FDA website.

AONN+ understands the concern that this creates and assures you that we remain steadfast in our commitment to supporting our members, their patients, and the navigation community through these challenging times.

We encourage all navigators to lean into your AONN+ community and resources, including the Oncology Navigation Standards of Professional Practice as outlined in our recent statement.

CRANBURY, NJ (Sept. 19, 2024) – The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to announce that Candice Roth, MSN, RN, CENP, has joined the association as its Executive Director. AONN+ is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurses and patient navigators.

Cranbury, NJ (February 28, 2024)—The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to share that PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostic industries, has named AONN+’s estrogen-receptor-positive (ER+) Premenopausal Breast Cancer Journey Pathway, supported by TerSera Therapeutics, as the Pharma Choice Award – Variety Silver Winner.

CRANBURY, NJ (Oct. 4, 2023) – The Academy of Oncology Nurse & Patient Navigators’ (AONN+) National Navigation Acuity Taskforce is developing a standardized, validated, evidence-based Navigation Acuity Tool for oncology navigation programs. When finalized, the acuity tool is expected to help oncology navigators characterize the intensity of the patient navigation workload, aid in the allocation of resources, and measure the effectiveness of navigation on patient outcomes.

CRANBURY, NJ—Each year, the AONN+ Leadership Council strives to bring novel ideas and perspectives to the table through the addition of new members.

CRANBURY, NJ (Aug. 11, 2023)—Patient navigation is one of the only evidence-based interventions that effectively addresses disparities in oncology care.

In recognition of the recent announcement by the Centers for Medicare & Medicaid Services (CMS) proposing payment for community health integration services, the Academy of Oncology Nurse & Patient Navigators (AONN+) sees this opportunity as a key initiative to strengthen and accelerate the oncology navigation footprint in every community.